ACRO Biomedical Co., Ltd.

NT$160.00As of Sun 8 Nov 2026, 12:00 UTC
TPEx:6748Healthcare
Country Taiwan
PE (Fwd) •••
TSR 5Y CAGR 39.35%
Div yield —
ROE (9.57%)
Biotechnology
Beta (5Y) 0.27
PE TTM —
TSR TTM 149.16%
Mkt cap NT$11.47B
ROIC (6.94%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$174
8.54%
1.91%
Hold 12|4|3|8|5
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
1.75
1.92
1.95
2.08
(2.15%)
9.80%
4.83%
15.45%
RevenueNT$B
1.406
1.471
1.545
1.537
3.44%
5.65%
6.50%
8.73%
Peers (US$347.5M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.491
0.957
0.817
EBIT/Intx
0.214
0.117
0.125
Own earn%
6.82
87.30
88.57
Sh yield%
32.54
52.33
52.35
Owners
Insiders/Inst%
13.59
83.77
Short interest%
3.02
SBC / revenue%
4.86
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
19–23
$1 testx
0.3
Incr. ROIC%
8